These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 29117314

  • 1. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW, Deppen SA, Mercaldo SF, Blume JD, Montgomery C, Vaszar LT, Williamson C, Isbell JM, Rickman OB, Pinkerman R, Lambright ES, Nesbitt JC, Grogan EL.
    JAMA Surg; 2018 Apr 01; 153(4):329-334. PubMed ID: 29117314
    [Abstract] [Full Text] [Related]

  • 2. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S, Lin X, Wang S, Shen Y, Meng Z, Jia Q, Tan J.
    Medicine (Baltimore); 2018 Aug 01; 97(31):e11640. PubMed ID: 30075545
    [Abstract] [Full Text] [Related]

  • 3. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ, Bastarrika G, de-Torres JP, Lozano MD, Sanchez-Salcedo P, Sancho L, Nuñez-Cordoba JM, Campo A, Alcaide AB, Torre W, Richter JA, Zulueta JJ.
    Lung Cancer; 2016 Jul 01; 97():81-6. PubMed ID: 27237032
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules.
    Taralli S, Scolozzi V, Foti M, Ricciardi S, Forcione AR, Cardillo G, Calcagni ML.
    Eur J Nucl Med Mol Imaging; 2019 Feb 01; 46(2):429-436. PubMed ID: 30535767
    [Abstract] [Full Text] [Related]

  • 5. ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
    Calcagni ML, Taralli S, Maggi F, Rufini V, Treglia G, Leccisotti L, Bonomo L, Giordano A.
    World J Surg Oncol; 2012 Apr 28; 10():71. PubMed ID: 22540935
    [Abstract] [Full Text] [Related]

  • 6. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
    Schwyzer M, Martini K, Benz DC, Burger IA, Ferraro DA, Kudura K, Treyer V, von Schulthess GK, Kaufmann PA, Huellner MW, Messerli M.
    Eur Radiol; 2020 Apr 28; 30(4):2031-2040. PubMed ID: 31822970
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 28; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov 28; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 9. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L, Panunzio A, Polverosi R, Pomerri F, Rubello D.
    AJR Am J Roentgenol; 2014 Mar 28; 202(3):507-14. PubMed ID: 24555586
    [Abstract] [Full Text] [Related]

  • 10. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
    Martins Rde C, Almeida SA, Siciliano AA, Landesmann MC, Silva FB, Franco CA, Fonseca LM.
    J Bras Pneumol; 2008 Jul 28; 34(7):473-80. PubMed ID: 18695792
    [Abstract] [Full Text] [Related]

  • 11. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M, Evangelista L, Fiordoro S, Porcaro F, Sicignano M, Mansi L.
    Curr Radiopharm; 2020 Jul 28; 13(3):243-248. PubMed ID: 32186274
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP.
    Chest; 1993 Oct 28; 104(4):997-1002. PubMed ID: 8404239
    [Abstract] [Full Text] [Related]

  • 13. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K.
    Chest; 1997 Aug 28; 112(2):416-22. PubMed ID: 9266877
    [Abstract] [Full Text] [Related]

  • 14. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
    Divisi D, Di Tommaso S, Di Leonardo G, Brianzoni E, De Vico A, Crisci R.
    Thorac Cardiovasc Surg; 2010 Oct 28; 58(7):422-6. PubMed ID: 20922626
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.
    AJR Am J Roentgenol; 2006 Nov 28; 187(5):1361-7. PubMed ID: 17056930
    [Abstract] [Full Text] [Related]

  • 16. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC, Pramesh CS, Agarwal JP, Agrawal A, Shah S, Prabhash K, Karimundackal G, Jiwnani S, Tandon S, Rangarajan V.
    Indian J Cancer; 2017 Nov 28; 54(1):271-275. PubMed ID: 29199704
    [Abstract] [Full Text] [Related]

  • 17. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
    Ohno Y, Kishida Y, Seki S, Yui M, Miyazaki M, Koyama H, Yoshikawa T.
    J Magn Reson Imaging; 2018 Apr 28; 47(4):1013-1021. PubMed ID: 28799280
    [Abstract] [Full Text] [Related]

  • 18. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
    Herder GJ, Golding RP, Hoekstra OS, Comans EF, Teule GJ, Postmus PE, Smit EF.
    Eur J Nucl Med Mol Imaging; 2004 Sep 28; 31(9):1231-6. PubMed ID: 15175835
    [Abstract] [Full Text] [Related]

  • 19. Computed Tomography-Guided Methylene Blue Labeling Prior to Thoracoscopic Resection of Small Deeply Placed Pulmonary Nodules. Do We Really Need Palpation?
    Findik G, Demiröz SM, Apaydın SMK, Ertürk H, Biri S, Incekara F, Aydogdu K, Kaya S.
    Thorac Cardiovasc Surg; 2017 Aug 28; 65(5):387-391. PubMed ID: 28131105
    [Abstract] [Full Text] [Related]

  • 20. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep 28; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.